HomeCompareEBSB vs PFE

EBSB vs PFE: Dividend Comparison 2026

EBSB yields 6.13% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EBSB wins by $20010.34M in total portfolio value
10 years
EBSB
EBSB
● Live price
6.13%
Share price
$24.15
Annual div
$1.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20010.39M
Annual income
$19,402,197,253.49
Full EBSB calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — EBSB vs PFE

📍 EBSB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEBSBPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EBSB + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EBSB pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EBSB
Annual income on $10K today (after 15% tax)
$520.91/yr
After 10yr DRIP, annual income (after tax)
$16,491,867,665.47/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, EBSB beats the other by $16,491,845,345.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EBSB + PFE for your $10,000?

EBSB: 50%PFE: 50%
100% PFE50/50100% EBSB
Portfolio after 10yr
$10005.22M
Annual income
$9,701,111,756.11/yr
Blended yield
96.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

EBSB
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EBSB buys
0
PFE buys
0
No recent congressional trades found for EBSB or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEBSBPFE
Forward yield6.13%6.13%
Annual dividend / share$1.48$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$20010.39M$49.6K
Annual income after 10y$19,402,197,253.49$26,258.71
Total dividends collected$19968.30M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: EBSB vs PFE ($10,000, DRIP)

YearEBSB PortfolioEBSB Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,926$1,225.67$9,153$693.39+$2.8KEBSB
2$15,493$2,732.14$8,593$849.25+$6.9KEBSB
3$23,211$6,634.25$8,336$1,066.78+$14.9KEBSB
4$43,415$18,578.62$8,437$1,384.80+$35.0KEBSB
5$111,406$64,952.65$9,013$1,875.40+$102.4KEBSB
6$430,746$311,541.57$10,306$2,680.72+$420.4KEBSB
7$2,712,407$2,251,508.64$12,820$4,101.38+$2.70MEBSB
8$29,402,712$26,500,435.94$17,673$6,826.70+$29.39MEBSB
9$568,408,257$536,947,354.92$27,543$12,591.86+$568.38MEBSB
10$20,010,394,088$19,402,197,253.49$49,560$26,258.71+$20010.34MEBSB

EBSB vs PFE: Complete Analysis 2026

EBSBStock

Meridian Bancorp, Inc. operates as the holding company for East Boston Savings Bank that provides various financial products and services for individuals and businesses primarily in Suffolk, Norfolk, Middlesex, and Essex Counties, Massachusetts. The company accepts various deposit products, including non-interest-bearing demand deposits, such as checking accounts; interest-bearing demand accounts, such as NOW and money market accounts; savings accounts; and certificates of deposit, as well as commercial checking accounts. Its loan portfolio includes commercial real estate loans, which are secured by properties, such as office buildings, industrial facilities, and retail facilities; one- to four-family residential loans, such as mortgage loans that enable borrowers to purchase or refinance existing homes; multi-family real estate loans; construction loans; commercial and industrial loans; home equity lines of credit; and consumer loans, including automobile loans, loans secured by savings or certificate accounts, credit builders, and annuity and overdraft loans. In addition, the company offers non-deposit financial products, such as mutual funds, annuities, stocks, and bonds through third-party broker-dealer; and long-term care insurance products. It is also involved in the securities transactions business. The company operates 42 full-service locations, one mobile branch, and three loan centers. Meridian Bancorp, Inc. was founded in 1848 and is based in Peabody, Massachusetts.

Full EBSB Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this EBSB vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EBSB vs SCHDEBSB vs JEPIEBSB vs OEBSB vs KOEBSB vs MAINEBSB vs JNJEBSB vs MRKEBSB vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.